News and Articles

Local News

Gene Therapy Startup’s Stock Stumbles after FDA Questions Treatment

Boston Business Journal | February 12, 2020

LogicBio Therapeutics had hoped to begin testing what could be the first gene-targeting treatment designed specifically…

sciencecityFebruary 12, 2020

Read More

Local News

Mass General Faculty To Present at McCourt Foundation Educational Update

Mass General News | February 12, 2020

On February 29, 2020, the McCourt Foundation will host its annual educational update about Alzheimer's,…

sciencecityFebruary 12, 2020

Read More

Local News

Going into Science: Women Scientists at Boston Children’s Offer Advice to Girls

Boston Children's Hospital | February 12, 2020

In honor of the International Day of Women and Girls in Science (February 11), we…

sciencecityFebruary 12, 2020

Read More

Local News

Elicio Therapeutics and Natera to Collaborate in Phase I/II Pancreatic Cancer Study of ELI-002

Natera | February 12, 2020

Elicio Therapeutics, a next generation immuno-oncology company, and Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free…

sciencecityFebruary 12, 2020

Read More

Local News

Studying Tools to Improve the Quality of Life for People with Cystic Fibrosis

Boston Children's Hospital | February 11, 2020

Thanks to advances in treatments in recent years, people with cystic fibrosis (CF) are living longer than…

sciencecityFebruary 11, 2020

Read More

Local News

Don’t Hate Your Guts – Heal Them

Harvard Gazette | February 11, 2020

Each one of us carries about 38 trillion bacteria around with us in our gut…

sciencecityFebruary 11, 2020

Read More

Local News

This Once-Faltering Cancer Startup Just Raised $117M. Here’s How It Plans to Spend It.

Boston Business Journal | February 11, 2020

When Jan Skvarka joined Cambridge’s Trillium Therapeutics Inc. as CEO in September 2019, the company had a…

sciencecityFebruary 11, 2020

Read More

Local News

Patient-Partnered Research Finds Clues about a Rare Cancer’s Genetic Roots

Dana-Farber Cancer Institute | February 11, 2020

For over three decades, Jim Chapdelaine thought he’d never meet another person who had the…

sciencecityFebruary 11, 2020

Read More

Local News

KSQ Therapeutics Announces Discovery Of Gene Targets With Potential Activity Superior To PD-1 For Development Of Engineered Tumor Infiltrating Lymphocyte (ETIL™) Therapies For Solid Tumors

KSQ Therapeutics | February 11, 2020

KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically screen the…

sciencecityFebruary 11, 2020

Read More

Featured Awards

UMass Worcester Prevention Research Center Funding Renewed

UMass Med Now | February 11, 2020

The UMass Worcester Prevention Research Center at UMass Medical School has been awarded a $3.75…

sciencecityFebruary 11, 2020

Read More